Impact of Covid-19 on Pharmaceuticals Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Description
Impact of Covid-19 on Pharmaceuticals Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Impact Of Covid-19 On The Pharmaceuticals Market
The impact of Covid-19 on the pharmaceuticals market size was valued at USD 1,494.67 billion in 2021, and the market is now projected to grow from USD 1,585.05 billion in 2022 to USD 2,401.22 billion by 2029, exhibiting a CAGR of 6.1% during the forecast period of 2022-2029.
The business has shifted its attention and prioritized the coronavirus which has hampered the market enlargement. Several medical assessments and work in a variety of therapy areas were turned down; the impact of Covid-19 on the pharmaceuticals market growth was not significantly hindered by the pandemic. Conversely the development was short-term and the market recovered their swiftness by implementing various strategies and plans in the challenge of lockdown. The market growth was pushed by the treatments and immunization courses.
The rising contagious incidences and chronic disease among citizens constantly are impelling the impact of Covid-19 on the pharmaceuticals market share globally. It is expanding due to an amplified patient population in the healthcare system. The patient population requiring personalized therapies is also increasing with the rising frequency and attentiveness of chronic conditions and transmittable diseases among the population. The rising per capita healthcare expenses in emerging and developed countries boost the number of patients undergoing treatment.
The trend is growing adoption of digital technologies across various fields in the medical sector to transform healthcare services. The market led to increased adherence to decentralized clinical trials. The augmented demand for decentralized clinical trial processes, from patient selection and enrollment to studying the trial outcomes. The trials processes and automation in the events are primary pharmacy companies to increase their research and development spending and actions to develop novel drugs and therapies.
Comprehensive Analysis of Impact Of Covid-19 On The Pharmaceuticals Market
This market development effectively provides a thorough regional assessment considering the dominant supply and demand forces that influenced the COVID-19 analysis industry. The impact of Covid-19 on the pharmaceuticals market and the trade of COVID-19 analysis are rising at a higher speed in consequence of the market segmentation. These segmentations are methodically segregated by type and distribution channel. The types are drugs (viral and bacterial diseases) and vaccines (diabetes, infectious diseases, and cardiology, oncology, neurology, respiratory, hypertension, and others). The distribution channels involve hospital, retail, and online pharmacies.
The North American region is conducive to the global impact of Covid-19 on the pharmaceuticals market, leading to a recall of USD 610.29 billion because of the progression in medical trials and presence of drug manufacturing in this region are supporting the market expansion.
The top players in the market play a crucial role in the COVID-19 analysis industry assuring industrial prospectus growth and setting market standards. These players include Sanofi (France), GSK plc. (U.K.), Johnson & Johnson Services Inc. (U.S.), Merck & Co., Inc. (U.S.), Novo Nordisk A/S (Denmark), Pfizer Inc. (U.S.), AstraZeneca (U.K.), and F. Hoffmann-La Roche Ltd. (Switzerland) are also major companies, these market players present a level-playing competitive landscape.
In June 2022, the U.S. FDA permitted Merck’s innovative immunizer, the VAXNEUVANCE. For, the insidious pneumococcal disease occurred in infants and children this vaccination is very useful for prevention.
Segmentation Table
Global Impact Of Covid-19 On The Pharmaceuticals Market Scope
ATTRIBUTE DETAILS
Study Period 2018-2029
Base Year 2021
Estimated Year 2022
Forecast Period 2022-2029
Historical Period 2018-2020
Unit Value (USD billion)
Segmentation Estimated Year
By Type Drugs
Oncology
Diabetes
Infectious Diseases
Cardiology
Neurology
Respiratory
Hypertension
Others
Vaccines
Viral Diseases
Bacterial Diseases
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
Latin America (Brazil, Mexico, Rest of Latin America)
Middle East & Africa (GCC, South Africa, and the Rest of Middle East & Africa)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
Table of Contents
215 Pages
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Impact of COVID-19 on the Supply Chain
- 4.2. Key Industry Developments – In Response to the COVID-19 Impact
- 4.3. Key Regulatory and Reimbursement Changes
- 4.4. Disruption of R&D projects in the Pharmaceuticals space with examples for major products/companies
- 4.5. Shift of R&D focus form other projects to COVID-19 the Pharmaceuticals space with examples for major products/companies
- 4.6. Impact of COVID-19 on the overall R&D and development of new products in the healthcare market
- 5. Key Insights – Pharmaceuticals Market (General)
- 5.1. Clinical Trials in Pharmaceuticals Market - Number of Trials, Size of the Industry, Number of Participants, Number of Sites, R&D Spending of Major Companies, Economic Impact of Clinical Trials
- 5.2. Success Rate of Drugs - Average Time and Price to Get a Drug on the Market, Proportion of Drugs that are Successful and Reach Blockbuster Status
- 5.3. Risk & Opportunities in Development of New Drugs – Qualitative Insights
- 6. Global Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
- 6.1. Market Analysis, Insights and Forecast – By Type
- 6.1.1. Drugs
- 6.1.1.1. Oncology
- 6.1.1.2. Diabetes
- 6.1.1.3. Infectious Diseases
- 6.1.1.4. Cardiology
- 6.1.1.5. Neurology
- 6.1.1.6. Respiratory
- 6.1.1.7. Hypertension
- 6.1.1.8. Others
- 6.1.2. Vaccines
- 6.1.2.1. Viral Diseases
- 6.1.2.2. Bacterial Diseases
- 6.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.2.1. Hospital Pharmacies
- 6.2.2. Retail Pharmacies
- 6.2.3. Online Pharmacies
- 6.3. Market Analysis, Insights and Forecast – By Geography
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. Asia Pacific
- 6.3.4. Latin America
- 6.3.5. Middle East & Africa
- 7. North America Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
- 7.1. Market Analysis, Insights and Forecast – By Type
- 7.1.1. Drugs
- 7.1.1.1. Oncology
- 7.1.1.2. Diabetes
- 7.1.1.3. Infectious Diseases
- 7.1.1.4. Cardiology
- 7.1.1.5. Neurology
- 7.1.1.6. Respiratory
- 7.1.1.7. Hypertension
- 7.1.1.8. Others
- 7.1.2. Vaccines
- 7.1.2.1. Viral Diseases
- 7.1.2.2. Bacterial Diseases
- 7.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.2.1. Hospital Pharmacies
- 7.2.2. Retail Pharmacies
- 7.2.3. Online Pharmacies
- 7.3. Market Analysis, Insights and Forecast – By Country
- 7.3.1. U.S.
- 7.3.2. Canada
- 8. Europe Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
- 8.1. Market Analysis, Insights and Forecast – By Type
- 8.1.1. Drugs
- 8.1.1.1. Oncology
- 8.1.1.2. Diabetes
- 8.1.1.3. Infectious Diseases
- 8.1.1.4. Cardiology
- 8.1.1.5. Neurology
- 8.1.1.6. Respiratory
- 8.1.1.7. Hypertension
- 8.1.1.8. Others
- 8.1.2. Vaccines
- 8.1.2.1. Viral Diseases
- 8.1.2.2. Bacterial Diseases
- 8.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.2.1. Hospital Pharmacies
- 8.2.2. Retail Pharmacies
- 8.2.3. Online Pharmacies
- 8.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 8.3.1. U.K.
- 8.3.2. Germany
- 8.3.3. France
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Rest of Europe
- 9. Asia Pacific Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
- 9.1. Market Analysis, Insights and Forecast – By Type
- 9.1.1. Drugs
- 9.1.1.1. Oncology
- 9.1.1.2. Diabetes
- 9.1.1.3. Infectious Diseases
- 9.1.1.4. Cardiology
- 9.1.1.5. Neurology
- 9.1.1.6. Respiratory
- 9.1.1.7. Hypertension
- 9.1.1.8. Others
- 9.1.2. Vaccines
- 9.1.2.1. Viral Diseases
- 9.1.2.2. Bacterial Diseases
- 9.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.2.1. Hospital Pharmacies
- 9.2.2. Retail Pharmacies
- 9.2.3. Online Pharmacies
- 9.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 9.3.1. Japan
- 9.3.2. China
- 9.3.3. India
- 9.3.4. Australia
- 9.3.5. South East Asia
- 9.3.6. Rest of Asia Pacific
- 10. Latin America Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
- 10.1. Market Analysis, Insights and Forecast – By Type
- 10.1.1. Drugs
- 10.1.1.1. Oncology
- 10.1.1.2. Diabetes
- 10.1.1.3. Infectious Diseases
- 10.1.1.4. Cardiology
- 10.1.1.5. Neurology
- 10.1.1.6. Respiratory
- 10.1.1.7. Hypertension
- 10.1.1.8. Others
- 10.1.2. Vaccines
- 10.1.2.1. Viral Diseases
- 10.1.2.2. Bacterial Diseases
- 10.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 10.2.1. Hospital Pharmacies
- 10.2.2. Retail Pharmacies
- 10.2.3. Online Pharmacies
- 10.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
- 11. Middle East & Africa Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
- 11.1. Market Analysis, Insights and Forecast – By Type
- 11.1.1. Drugs
- 11.1.1.1. Oncology
- 11.1.1.2. Diabetes
- 11.1.1.3. Infectious Diseases
- 11.1.1.4. Cardiology
- 11.1.1.5. Neurology
- 11.1.1.6. Respiratory
- 11.1.1.7. Hypertension
- 11.1.1.8. Others
- 11.1.2. Vaccines
- 11.1.2.1. Viral Diseases
- 11.1.2.2. Bacterial Diseases
- 11.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 11.2.1. Hospital Pharmacies
- 11.2.2. Retail Pharmacies
- 11.2.3. Online Pharmacies
- 11.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 11.3.1. GCC
- 11.3.2. South Africa
- 11.3.3. Rest of Middle East & Africa
- 12. Competitive Analysis
- 12.1. Key Industry Developments
- 12.2. Global Market Share Analysis (2021)
- 12.3. Profiles of Players Operating in the Market (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (based on availability))
- 12.3.1. AstraZeneca
- 12.3.1.1. Overview,
- 12.3.1.2. Products,
- 12.3.1.3. SWOT Analysis,
- 12.3.1.4. Recent Developments,
- 12.3.1.5. Strategies,
- 12.3.1.6. financials (based on availability)
- 12.3.2. F. Hoffmann-La Roche Ltd.
- 12.3.2.1. Overview,
- 12.3.2.2. Products,
- 12.3.2.3. SWOT Analysis,
- 12.3.2.4. Recent Developments,
- 12.3.2.5. Strategies,
- 12.3.2.6. financials (based on availability)
- 12.3.3. GlaxoSmithKline plc
- 12.3.3.1. Overview,
- 12.3.3.2. Products,
- 12.3.3.3. SWOT Analysis,
- 12.3.3.4. Recent Developments,
- 12.3.3.5. Strategies,
- 12.3.3.6. financials (based on availability)
- 12.3.4. Johnson & Johnson Services Inc.
- 12.3.4.1. Overview,
- 12.3.4.2. Products,
- 12.3.4.3. SWOT Analysis,
- 12.3.4.4. Recent Developments,
- 12.3.4.5. Strategies,
- 12.3.4.6. financials (based on availability)
- 12.3.5. Merck & Co., Inc.
- 12.3.5.1. Overview,
- 12.3.5.2. Products,
- 12.3.5.3. SWOT Analysis,
- 12.3.5.4. Recent Developments,
- 12.3.5.5. Strategies,
- 12.3.5.6. financials (based on availability)
- 12.3.6. Novo Nordisk A/S
- 12.3.6.1. Overview,
- 12.3.6.2. Products,
- 12.3.6.3. SWOT Analysis,
- 12.3.6.4. Recent Developments,
- 12.3.6.5. Strategies,
- 12.3.6.6. financials (based on availability)
- 12.3.7. Novartis AG
- 12.3.7.1. Overview,
- 12.3.7.2. Products,
- 12.3.7.3. SWOT Analysis,
- 12.3.7.4. Recent Developments,
- 12.3.7.5. Strategies,
- 12.3.7.6. financials (based on availability)
- 12.3.8. Pfizer Inc.
- 12.3.8.1. Overview,
- 12.3.8.2. Products,
- 12.3.8.3. SWOT Analysis,
- 12.3.8.4. Recent Developments,
- 12.3.8.5. Strategies,
- 12.3.8.6. financials (based on availability)
- 12.3.9. Sanofi
- 12.3.9.1. Overview,
- 12.3.9.2. Products,
- 12.3.9.3. SWOT Analysis,
- 12.3.9.4. Recent Developments,
- 12.3.9.5. Strategies,
- 12.3.9.6. financials (based on availability)
- 13. Strategic Recommendations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
